Is Pregnancy Protective from Rebound After Fingolimod Cessation?
Clinical Medicine & Research · 2026-09 · 24 (3) · 137-140
DOI: 10.3121/cmr.2026.2064 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Medicine & Research, 2026-09. Verfasst von Foziah J AlShamrani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Imam Abdurrahman Bin Faisal University, College of Medicine, Neurology Department, King Fahad Hospital of the University in Khobar, Eastern province,…. Hauptthemen laut MEDLINE: Fingolimod Hydrochloride, Multiple Sclerosis, Pregnancy Complications, Immunosuppressive Agents. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Imam Abdurrahman Bin Faisal University, College of Medicine, Neurology Department, King Fahad Hospital of the University in Khobar, Eastern province, Saudi Arabia.
Zitieren
APA
AlShamrani, F. J., Alqarni, A. M., Alakloby, E. O., AlDamigh, F. A., & Shariff, E. (2026). Is Pregnancy Protective from Rebound After Fingolimod Cessation?. Clinical Medicine & Research, 24(3), 137-140. https://doi.org/10.3121/cmr.2026.2064
Vancouver
AlShamrani FJ, Alqarni AM, Alakloby EO, AlDamigh FA, Shariff E. Is Pregnancy Protective from Rebound After Fingolimod Cessation?. Clinical Medicine & Research. 2026;24(3):137-140. doi:10.3121/cmr.2026.2064
BibTeX
@article{AlShamrani2026,
author = {AlShamrani, Foziah J and Alqarni, Abdulaziz M and Alakloby, Esra O and AlDamigh, Fahad A and Shariff, Erum},
title = {Is Pregnancy Protective from Rebound After Fingolimod Cessation?},
journal = {Clinical Medicine & Research},
year = {2026},
volume = {24},
number = {3},
pages = {137--140},
doi = {10.3121/cmr.2026.2064}
}
EUVIMED